North China Pharmaceutical: Injection of vancomycin hydrochloride obtained drug registration certificate.

Northern China Pharmaceuticals announced in the evening that recently the company has received the Drug Registration Certificate for injection of Vancomycin Hydrochloride issued by the National Medical Products Administration, which is considered to have passed the evaluation of generic drug quality and consistency of efficacy. Vancomycin Hydrochloride mainly exerts bactericidal effect by inhibiting the biosynthesis of cell walls. In addition, Vancomycin can change the permeability of bacterial cell membranes and RNA synthesis. Its intravenous infusion is suitable for infections caused by methicillin-resistant Staphylococcus aureus and other bacteria.